These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5707872)

  • 21. [Gamma-glutamyl-transpeptidase in certain internal diseases].
    Bednarzewski J; Rozek S
    Wiad Lek; 1966 Feb; 19(4):271-5. PubMed ID: 5946935
    [No Abstract]   [Full Text] [Related]  

  • 22. [Bile electrolytes in patients with chronic diseases of the liver and bile ducts].
    Revutskiĭ BI; Shmakov VN; Nechaev EN
    Vrach Delo; 1969 Oct; 10():118-20. PubMed ID: 5366772
    [No Abstract]   [Full Text] [Related]  

  • 23. [Metabolic capacity of the liver for drugs in hepatobiliary patients].
    González Macias J; Herreros Fernández V; De Castro Del Pozo S
    Rev Clin Esp; 1975 Jan; 136(2):123-30. PubMed ID: 1121588
    [No Abstract]   [Full Text] [Related]  

  • 24. [The use of antioxidants in patients with chronic diseases of the hepatobiliary system (a review of the literature)].
    Epishin AV; Rudiak GI
    Vrach Delo; 1990 Apr; (4):24-7. PubMed ID: 2275156
    [No Abstract]   [Full Text] [Related]  

  • 25. [The pathogenesis of hypercholesterolemia after biliary obstruction (author's transl)].
    Weis HJ; Baas EU
    Klin Wochenschr; 1974 Dec; 52(23):1122-7. PubMed ID: 4444230
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pathobiochemical aspects of interactions between glycoproteins and glycoprotein receptors].
    Köttgen E; Gerok W
    Med Welt; 1979 Jan; 30(1):20-9. PubMed ID: 759800
    [No Abstract]   [Full Text] [Related]  

  • 27. [Properdin system and liver diseases].
    Reissmann G
    Z Gesamte Inn Med; 1970 Apr; 25(7):297-300. PubMed ID: 5521440
    [No Abstract]   [Full Text] [Related]  

  • 28. Serum ceruloplasmin in hepatobiliary and other disorders: significance of abnormal values.
    Gault MH; Stein J; Aronoff A
    Gastroenterology; 1966 Jan; 50(1):8-18. PubMed ID: 5900960
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute cholestasis in the rat.
    Garay EA; Piccaluga A; Perez V; Royer M; Listrani J
    Acta Hepatosplenol; 1969; 16(4):221-30. PubMed ID: 5805605
    [No Abstract]   [Full Text] [Related]  

  • 30. [Lipid content of the bile in diseases of the biliary tract in male and female Evenkis].
    Sedov KR; Pukanov VV
    Klin Med (Mosk); 1995; 73(4):66-8. PubMed ID: 7474826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The valve of the determination of the ornithine-carbamyl transferase in the serum and its comparison with the determination of the glutamo-pyruvic transaminase in clinical hepatology].
    Cachin M; Girard ML; Charbonnier A; Rousselet F; Koch M; Khoury K
    Pathol Biol; 1965 May; 13(9):477-88. PubMed ID: 5320274
    [No Abstract]   [Full Text] [Related]  

  • 32. [Circulation of ampicillin and sulfalene in liver disease patients].
    Iakovlev VP; Bobrov VI; Gal'perin EI; Volkova NV; Nazarova OI
    Antibiotiki; 1982 Aug; 27(8):619-23. PubMed ID: 7125622
    [No Abstract]   [Full Text] [Related]  

  • 33. [Lipid composition of blood serum and bile in biliary diseases in patients with diabetes mellitus].
    Tsukanov VV; Selivestrova EV; Dogadin SA
    Ter Arkh; 2005; 77(2):15-8. PubMed ID: 15807443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The bile acid and bile lipid spectrum of the migrant population of the Asian North with biliary tract diseases].
    Tsukanov VV; Tonkikh IuL
    Ter Arkh; 1998; 70(2):44-6. PubMed ID: 9551571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lipoprotein lipase and glycoprotein of the blood].
    Vallino F; Pagliano F; Rugarli C
    G Gerontol; 1966 Nov; 14(11):1011-9. PubMed ID: 5998254
    [No Abstract]   [Full Text] [Related]  

  • 36. [Lipid metabolism in newborn infants at birth. Obstetrical-pediatric aspects].
    Meduri F; Ferrazzani S; Lombardo F; Moneta E; Miggiano G; Martorana A
    Minerva Med; 1980 Sep; 71(36):2583-8. PubMed ID: 7432679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In situ monitoring of caspase activation in hepatobiliary diseases.
    Bantel H; Ruck P; Schulze-Osthoff K
    Cell Death Differ; 2000 May; 7(5):504-5. PubMed ID: 10917736
    [No Abstract]   [Full Text] [Related]  

  • 38. [Disorders of lipid metabolism in biliary tract diseases].
    Gorbachev VV; Bronovets IN
    Klin Med (Mosk); 1978 Jun; 56(6):67-72. PubMed ID: 672165
    [No Abstract]   [Full Text] [Related]  

  • 39. [Serum iron and copper levels and serum activity of phosphohexoisomerase and glutamic-pyruvic transaminase in patients with liver and biliary tract disease].
    Switlik I; Szymańska H; Myśliwicz-Rychlik H
    Pol Arch Med Wewn; 1966; 36(3):365-70. PubMed ID: 5941685
    [No Abstract]   [Full Text] [Related]  

  • 40. Electrophoretic studies on liver protein. IV. A speciality of liver and biliary tract diseases viewed from liver protein patterns.
    SATO T; KOSEKI K; WATANABE K; KUROKOCHI I; TAKAHASHI M
    Tohoku J Exp Med; 1961 Feb; 73():252-6. PubMed ID: 13746721
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.